Scarica l'app Stockscreener
6.28
2.94%
-0.19
Dopo l'orario di chiusura:
6.29
0.010
+0.16%
Precedente Chiudi:
$6.47
Aprire:
$6.34
Volume 24 ore:
2.95M
Relative Volume:
0.65
Capitalizzazione di mercato:
$1.14B
Reddito:
$2.51B
Utile/perdita netta:
$-171.15M
Rapporto P/E:
-6.5193
EPS:
-0.9633
Flusso di cassa netto:
$122.59M
1 W Prestazione:
-3.38%
1M Prestazione:
-6.41%
6M Prestazione:
+22.42%
1 anno Prestazione:
-17.69%
Intervallo 1D:
$6.25
$6.42
Intervallo di 1 settimana:
$6.17
$6.61
Portata 52W:
$4.40
$9.8868
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, TXG, HQY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.28 | 1.18B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
275.09 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.73 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.62 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
62.65 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.07 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-02-26 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-07-25 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Here's Why Teladoc's Integrated Care Business Deserves More Attention - tradingview.com
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Bliss Kelly - Moomoo
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
Teladoc Health (TDOC) CEO sells 18,327 shares after stock awards vest - Stock Titan
Equity awards vest for Teladoc Health (NYSE: TDOC) accounting chief - Stock Titan
15,311 stock units vest for Teladoc (TDOC) exec as she sells shares for taxes - Stock Titan
Teladoc Health (TDOC) exec sells shares to cover taxes after 14,928 units vest - Stock Titan
RSU vesting prompts Teladoc (TDOC) executive to sell shares for taxes - Stock Titan
Teladoc Health (NYSE: TDOC) president sells 15,251 shares - Stock Titan
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Teladoc Health (NYSE: TDOC) officer plans sale of 9,812 recently vested shares - Stock Titan
Chutes & Ladders—Teladoc Health taps new CFO; Johns Hopkins Health Plan names interim CEO - Fierce Healthcare
Planned stock sale by Teladoc (NYSE: TDOC) officer covers 7,357 shares - Stock Titan
Teladoc Health (NYSE: TDOC) insider lines up 5,439-share stock sale tied to vested awards - Stock Titan
Teladoc (NYSE: TDOC) exec plans stock sale, including shares to cover taxes on vested stock - Stock Titan
Teladoc (NYSE: TDOC) officer plans $39K stock sale - Stock Titan
Teladoc Health (NYSE: TDOC) holder plans 18,327-share Rule 144 sale - Stock Titan
Teladoc Health stock rises on a new CFO and steady July results - AD HOC NEWS
Here's Why Investors Should Stay Neutral on TDOC Stock for Now - tradingview.com
Teladoc Health Appoints Michael Grasher as New CFO - The Globe and Mail
Insider at Teladoc (TDOC) reports new stock trades - Stock Titan
Teladoc (NYSE: TDOC) CFO Michael Grasher listed as insider with no trades reported - Stock Titan
What Teladoc Health (TDOC)'s New Insurance-Focused CFO Appointment Means For Shareholders - simplywall.st
Teladoc nabs insurance veteran as new CFO - Healthcare Dive
Teladoc appoints insurance executive Michael Grasher as CFO - Y100 WNCY
Teladoc Health names Michael Grasher as chief financial officer By Investing.com - Investing.com South Africa
Teladoc Health names Michael Grasher as chief financial officer - Investing.com
Teladoc Health Appoints Michael Grasher as Chief Financial Officer - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
Teladoc Health (TDOC) Director Exit Keeps Fair Value Debate In Focus - finance.yahoo.com
Teladoc Health (TDOC) Is Down 6.2% After Cutting 2026 Outlook And BetterHelp StrainsHas The Bull Case Changed? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC (TDOC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Morningstar
Law firm probes Teladoc Health officers for pos... - Pluang
2026-08-16 | Teladoc Health, Inc. (TDOC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:TDOC | Press Release - Stockhouse
5 Best Telemedicine and Telehealth Stocks for 2026 and How to Invest - The Motley Fool
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Healthcare giants team up for new adolescent behavioral care initiative - AOL.com
Truist Securities Adjusts Price Target on Teladoc Health to $8 From $9, Keeps Hold Rating - marketscreener.com
Teladoc Health (TDOC) Could Be 55% Undervalued On Board Change And 2026 Guidance - Sahm
Teladoc's David B. Snow, Jr. to Retire from Board on Sept 30, 2026 - TradingView
Teladoc Health, Inc. (TDOC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teladoc Health, Inc. (TDOC) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Catapano Joseph Ronald - Moomoo
Teladoc Health (TDOC) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teladoc Health, Inc. (TDOC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Teladoc Health | 8-K: Current report - moomoo.com
Teladoc Health, Inc. (TDOC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Teladoc Health, Inc. Stock 12‑Month Price Target Cut to $7.5, Implies 5% Upside - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teladoc Health, Inc. (TDOC) And Encourages Investors to Connect - ACCESS Newswire
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Teladoc Health Inc Azioni (TDOC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Catapano Joseph Ronald | Chief Accounting Officer |
Jul 02 '26 |
Sale |
9.10 |
653 |
5,942 |
12,267 |
0.03%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):